Canoy, Romeo N.

HRN: 24-04-28  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/04/2024
CEFUROXIME 1.5GM (VIAL)
01/04/2024
01/11/2024
IV
1.5g
Q8hrs PTOR
Cholelithiasis
Waiting Final Action 
01/04/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/04/2024
01/11/2024
IV
500mg
Q8hrs PTOR
Cholelithiasis
Waiting Final Action 
01/05/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/05/2024
01/12/2024
IV
500 Mg
Q8h
Cholecystectomy
Waiting Final Action 
01/05/2024
CEFUROXIME 1.5GM (VIAL)
01/05/2024
01/12/2024
IV
1.5
Q8h
Cholecystectomy
Waiting Final Action 
01/07/2024
METRONIDAZOLE 500MG (TAB)
01/07/2024
01/14/2024
PO
500mg
TID
Cholecystectomy
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: